Status:
ACTIVE_NOT_RECRUITING
Cluster Headache Treatment Survey
Lead Sponsor:
The University of Texas Health Science Center, Houston
Collaborating Sponsors:
Clusterbusters, Inc.
Conditions:
Cluster Headache
Eligibility:
All Genders
18+ years
Brief Summary
The objective of this study is to survey patients with cluster headache about treatment effectiveness and their views on treatments. Participants will complete one brief questionnaire online.
Eligibility Criteria
Inclusion
- Patients with episodic or chronic cluster headache that has been diagnosed by a health care professional (no documentation is needed, participant must simply state that he or she has been diagnosed)
Exclusion
- Unable to speak English (the survey is only in English)
- Unable to use a computer to take the online survey
- Unable to provide consent
Key Trial Info
Start Date :
June 29 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 28 2025
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT06011811
Start Date
June 29 2023
End Date
June 28 2025
Last Update
June 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Texas Health Science Center at Houston
Houston, Texas, United States, 77030